John A. Storwick, Herman Tam, Daniel G. Rosenbaum, & Kristin Houghton. (2024). Checkpoint inhibitor immunotherapy induced inflammatory arthritis secondary to Nivolumab and Ipilimumab: A pediatric first. BMC.
Chicago Style (17th ed.) CitationJohn A. Storwick, Herman Tam, Daniel G. Rosenbaum, and Kristin Houghton. Checkpoint Inhibitor Immunotherapy Induced Inflammatory Arthritis Secondary to Nivolumab and Ipilimumab: A Pediatric First. BMC, 2024.
MLA (9th ed.) CitationJohn A. Storwick, et al. Checkpoint Inhibitor Immunotherapy Induced Inflammatory Arthritis Secondary to Nivolumab and Ipilimumab: A Pediatric First. BMC, 2024.
Warning: These citations may not always be 100% accurate.